CLINICAL_TRIALS
trial_result
· 2018-09-25
Clinical Trial Update: Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines [Phase 4]
Summary
Phase 4 trial comparing Dysport reconstitution at 1.5 mL vs 2.5 mL for moderate to severe glabellar lines; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Glabellar Lines, Wrinkles | Phase 4 | Status: COMPLETED | Results posted: 2018-09-25